Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1978 Nov-Dec;51(6):615–623.

Inhibition of Lymphocyte Cytotoxicity by Serum from Patients with Alcoholic Liver Disease: Partial Characterization of Serum Inhibitors

J R Wands, J L Dienstag
PMCID: PMC2595598  PMID: 313125

Abstract

Studies were performed to explore the effect on normal lymphocyte function of serum derived from patients with alcohol-induced liver injury and healthy controls. We examined the effect of such serum on the generation of both spontaneous and Concanavalin A (Con A)-induced lymphocyte cytotoxicity for Chang target cells. Normal lymphocytes, when incubated in the presence of 5% serum from patients with alcoholic liver disease, showed a marked (20.75 ± 5.1% mean ± SEM) reduction in the capacity to generate spontaneously cytotoxic cells compared to 5% control serum (3.2 ± 1.9%) (p < 0.001). Similar results were found in studies of Con A-stimulated cytotoxicity (36 ± 7.2% vs. 5 ± 2.3%; p < 0.001). Fractionation of serum by gel chromatography demonstrated the presence of inhibitory activity of various molecular weights, although a major peak of inhibitory activity (approximately 270,000 daltons) was identified in severe alcoholic hepatitis. Thus, this study demonstrates the presence of serum inhibitors in alcoholic liver disease which influence normal lymphocyte function.

Full text

PDF
615

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berenyi M. R., Straus B., Cruz D. In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis. Am J Dig Dis. 1974 Mar;19(3):199–205. doi: 10.1007/BF01072535. [DOI] [PubMed] [Google Scholar]
  2. Bernstein I. M., Webster K. H., Williams R. C., Jr, Strickland R. G. Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet. 1974 Aug 31;2(7879):488–490. doi: 10.1016/s0140-6736(74)92015-7. [DOI] [PubMed] [Google Scholar]
  3. Chisari F. V., Routenberg J. A., Edgington T. S. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. J Clin Invest. 1976 May;57(5):1227–1238. doi: 10.1172/JCI108391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chisari F. V., Routenberg J. A., Fiala M., Edgington T. S. Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis. J Clin Invest. 1977 Jan;59(1):134–142. doi: 10.1172/JCI108610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cochrane A. M., Moussouros A., Portmann B., McFarlane I. G., Thomson A. D., Eddleston, Williams R. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology. 1977 May;72(5 Pt 1):918–923. [PubMed] [Google Scholar]
  6. DeMeo A. N., Andersen B. R. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972 Apr 6;286(14):735–740. doi: 10.1056/NEJM197204062861401. [DOI] [PubMed] [Google Scholar]
  7. Fox R. A., Dudley F. J., Samuels M., Milligan J., Sherlock S. Lymphocyte transformation in response to phytohaemagglutinin in primary biliary cirrhosis: the search for a plasma inhibitory factor. Gut. 1973 Feb;14(2):89–93. doi: 10.1136/gut.14.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Galambos J. T. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology. 1972 Dec;63(6):1026–1035. [PubMed] [Google Scholar]
  9. Hsu C. C., Leevy C. M. Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol. 1971 May;8(5):749–760. [PMC free article] [PubMed] [Google Scholar]
  10. Husby G., Strickland R. G., Caldwell J. L., Williams R. C., Jr Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease. J Clin Invest. 1975 Nov;56(5):1198–1209. doi: 10.1172/JCI108197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kakumu S., Leevy C. M. Lymphocyte cytotoxicity in alcoholic hepatitis. Gastroenterology. 1977 Apr;72(4 Pt 1):594–597. [PubMed] [Google Scholar]
  12. MacSween R. N., Thomas M. A. Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors. Clin Exp Immunol. 1973 Dec;15(4):523–533. [PMC free article] [PubMed] [Google Scholar]
  13. Mella B. A., Taswell H. F. Suppression of leukocytic mitosis by sera of hepatitis-implicated donors. Am J Clin Pathol. 1970 Feb;53(2):141–144. doi: 10.1093/ajcp/53.2.141. [DOI] [PubMed] [Google Scholar]
  14. Mella B., Lang D. J. Leukocyte mitosis: suppression in vitro associated with acute infectious hepatitis. Science. 1967 Jan 6;155(3758):80–81. doi: 10.1126/science.155.3758.80. [DOI] [PubMed] [Google Scholar]
  15. Mihas A. A., Bull D. M., Davidson C. S. Cell-mediated immunity to liver in patients with alcoholic hepatitis. Lancet. 1975 Apr 26;1(7913):951–953. doi: 10.1016/s0140-6736(75)92009-7. [DOI] [PubMed] [Google Scholar]
  16. Nelson D. L., Bundy B. M., Pitchon H. E., Blaese R. M., Strober W. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1976 Nov;117(5 Pt 1):1472–1481. [PubMed] [Google Scholar]
  17. Newberry W. M., Shorey J. W., Sanford J. P., Combes B. Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cell Immunol. 1973 Jan;6(1):87–97. doi: 10.1016/0008-8749(73)90009-9. [DOI] [PubMed] [Google Scholar]
  18. Paronetto F., Lieber C. S. Cytotoxicity of lymphocytes in experimental alcoholic liver injury in the baboon. Proc Soc Exp Biol Med. 1976 Dec;153(3):495–497. doi: 10.3181/00379727-153-39576. [DOI] [PubMed] [Google Scholar]
  19. Straus B., Berenyi M. R., Huang J. M., Straus E. Delayed hypersensitivity in alcoholic cirrhosis. Am J Dig Dis. 1971 Jun;16(6):509–516. doi: 10.1007/BF02235541. [DOI] [PubMed] [Google Scholar]
  20. Vierling J. M., Nelson D. L., Strober W., Bundy D. M., Jones E. A. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. J Clin Invest. 1977 Nov;60(5):1116–1128. doi: 10.1172/JCI108863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wands J. R., Perrotto J. L., Alpert E., Isselbacher K. J. Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest. 1975 May;55(5):921–929. doi: 10.1172/JCI108021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zetterman R. K., Leevy C. M. Immunologic reactivity and alcoholic liver disease. Bull N Y Acad Med. 1975 Apr;51(4):533–544. [PMC free article] [PubMed] [Google Scholar]
  23. Zetterman R. K., Luisada-Opper A., Leevy C. M. Alcoholic hepatitis. Cell-mediated immunological response to alcoholic hyalin. Gastroenterology. 1976 Mar;70(3):382–384. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES